77 results on '"Bednarski, Jeffrey J."'
Search Results
2. Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc
3. Donor-Derived Memory-like NK Cells for the Treatment of Children and Young Adults with Relapsed AML Following Allo-HCT
4. Assessing DNA Damage Responses Using B Lymphocyte Cultures
5. Pediatric Necrobiotic Xanthogranuloma as a Novel Phenotype of IKAROS Gain of Function
6. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks
7. The SMC5/6 complex is required for maintenance of genome integrity upon APOBEC3A-mediated replication stress
8. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study
9. Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD
10. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
11. Brief IL-12, IL-15, IL-18 activation drives the acquisition of two distinct memory-like NK cell states
12. Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy
13. Attaining Therapeutic Busulfan Pharmacokinetic Ranges Utilizing a Busulfan Nomogram without Adverse Effects on Organ Systems and Survival: One Institution’s Experience
14. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions
15. Allogenic Hematopoietic Cell Transplantations Are Effective in Patients with p47phox Chronic Granulomatous Disease: A Primary Immune Deficiency Treatment Consortium Study
16. Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin
17. Nuclease‐independent functions of RAG1 direct distinct DNA damage responses in B cells
18. BCLAF1 Regulates Expression of AP-1 Genes and Fetal Hematopoietic Stem Cell Repopulation Activity
19. DNA Damage Signals Repress SYK in Early B Cells to Limit Leukemic Transformation
20. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
21. Hematology and Oncology
22. Bclaf1 promotes hematopoietic stem cell repopulating capacity and self-renewal
23. Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant
24. Cytokine-Induced Memory-like NK Cells Have a Distinct Single Cell Transcriptional Profile and Persist for Months in Adult and Pediatric Leukemia Patients after Adoptive Transfer
25. Immunological Findings and Clinical Outcomes of Infants With Positive Newborn Screening for Severe Combined Immunodeficiency From a Tertiary Care Center in the U.S.
26. Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function
27. Contemporary strategies in stem cell transplantation for chronic granulomatous disease
28. A Case of Severe Combined Immunodeficiency Missed by Newborn Screening
29. Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC Centers
30. Lymphocyte Development: Integration of DNA Damage Response Signaling
31. Recovery from COVID-19 in a Child with Chronic Granulomatous Disease and T Cell Lymphopenia
32. A Novel CYBB Variant Causing X-Linked Chronic Granulomatous Disease in a Patient with Empyema
33. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers
34. Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders
35. Incidence and treatment of hemophagocytic lymphohistiocytosis in hospitalized children with Ehrlichia infection
36. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis
37. DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner
38. Third-Party Virus-Specific T-Cell Infusion for Treatment of Refractory Viral Infections: Interim Results from PBMTC SUP1701
39. Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC)
40. Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey
41. The Tetraspanin CD53 Regulates Early B Cell Development by Promoting IL-7R Signaling
42. The Tetraspanin CD53 Regulates Early B Cell Development By Promoting IL-7R Signaling
43. Adoptively Transferred Donor-Derived Cytokine Induced Memory-like NK Cells Persist and Induce Remission in Pediatric Patient with Relapsed Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
44. A single‐center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease
45. RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex
46. Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients
47. Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients
48. At the intersection of DNA damage and immune responses
49. Bclaf1 Promotes Maintenance and Self-Renewal of Fetal Hematopoietic Stem Cells
50. Erratum for Franco et al., “A Novel Secreted Protein, MYR1, Is Central to Toxoplasma ’s Manipulation of Host Cells”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.